LC
ALXN

Lourd Capital’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Lourd Capital’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,847
Closed -$221K – 347
2017
Q4 		$221K Buy
+1,847
New +$221K 0.01% 315